Evidence map

ReviewCancers2022

Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Jérémy H Raymond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35158973